Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 11/20 | 0.68 |
| ▸ | HRH1 | P35367 | 5/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.63 |
| ▸ | HTR2A | P28223 | 5/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.63 |
| ▸ | DRD2 | P14416 | 4/20 | 0.63 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.63 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.63 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.63 |
| ▸ | HTR2C | P28335 | 4/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.63 |
| ▸ | DRD3 | P35462 | 4/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.63 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.63 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218473 | 0.85 | SLC6A4 (0.66) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL26967791 | 0.85 | SLC6A4 (0.69) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL220948 | 0.84 | SLC6A4 (0.61) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL8724668 | 0.84 | SLC6A4 (0.61) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL29843225 | 0.84 | SLC6A4 (0.61) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| Iodide SCHEMBL10598664 | 0.82 | SLC6A4 (0.52) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL220778 | 0.82 | SLC6A4 (0.62) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL9879795 | 0.82 | SLC6A4 (0.51) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL9490693 | 0.82 | SLC6A4 (0.72) | SLC6A4HRH1SLC6A2HTR2ACHRM1 | |
| SCHEMBL13040622 | 0.81 | SLC6A4 (0.63) | SLC6A4HRH1SLC6A2HTR2ACHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088918-B2 | Noncardiotoxic pharmaceutical compounds | WILLIAMSBURG HOLDINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088918-B2 | Noncardiotoxic pharmaceutical compounds | WILLIAMSBURG HOLDINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088918-B2 | Noncardiotoxic pharmaceutical compounds | WILLIAMSBURG HOLDINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| EP-1778252-A2 | NONCARDIOTOXIC PHARMACEUTICAL COMPOUNDS | Barbeau, Donald L. (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006020573-A2 | NONCARDIOTOXIC PHARMACEUTICAL COMPOUNDS | BARBEAU DONALD L (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060035863-A1 | Noncardiotoxic pharmaceutical compounds | B&G PARTNERS, LLC | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035863-A1 | Noncardiotoxic pharmaceutical compounds | KCNN3, TNNI3, TNNT2 | SLC6A4 380/4885HRH1 702/4885SLC6A2 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.